These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7901453)

  • 1. Common expression of the multidrug resistance marker P-glycoprotein in B-cell chronic lymphocytic leukaemia and correlation with in vitro drug resistance.
    Sparrow RL; Hall FJ; Siregar H; Van der Weyden MB
    Leuk Res; 1993 Nov; 17(11):941-7. PubMed ID: 7901453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical application of a rapid, functional assay for multidrug resistance based on accumulation of the fluorescent dye, fluo-3.
    Wall DM; Sparrow R; Hu XF; Nadalin G; Zalcberg JR; Marschner IC; Van der Weyden M; Parkin JD
    Eur J Cancer; 1993; 29A(7):1024-7. PubMed ID: 8098947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemomodulation of drugs involved in multidrug resistance in chronic lymphatic leukemia of the B-cell type.
    Reichle A; Diddens H; Altmayr F; Rastetter J; Andreesen R
    Cancer Chemother Pharmacol; 1994; 34(4):307-16. PubMed ID: 7913420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody.
    Fogler WE; Pearson JW; Volker K; Ariyoshi K; Watabe H; Riggs CW; Wiltrout RH; Longo DL
    J Natl Cancer Inst; 1995 Jan; 87(2):94-104. PubMed ID: 7707396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of the multidrug resistance-associated glycoprotein in B-cell chronic lymphocytic leukaemia.
    Michieli M; Raspadori D; Damiani D; Geromin A; Gallizia C; Michelutti A; Fanin R; Fasola G; Russo D; Tazzari P
    Br J Haematol; 1991 Apr; 77(4):460-5. PubMed ID: 1673863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
    Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
    J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two methods to detect P-glycoprotein in patients with chronic lymphocytic leukaemia.
    Chin-Yee I; Alshammari S; Anderson L; Kadri M; Keeney M
    Clin Lab Haematol; 1996 Jun; 18(2):99-104. PubMed ID: 8866142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-tubulin and P-glycoprotein: major determinants of vincristine accumulation in B-CLL cells.
    Reichle A; Diddens H; Altmayr F; Rastetter J; Andreesen R
    Leuk Res; 1995 Nov; 19(11):823-9. PubMed ID: 8551799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in chronic lymphocytic leukaemia.
    Grey MR; Burgess R; Fisher A; Yin JA
    Leuk Res; 1999 Jan; 23(1):29-35. PubMed ID: 9933132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of P-glycoprotein and alterations in topoisomerase II in P388 mouse leukemia cells selected in vivo for resistance to mitoxantrone.
    Kamath N; Grabowski D; Ford J; Kerrigan D; Pommier Y; Ganapathi R
    Biochem Pharmacol; 1992 Sep; 44(5):937-45. PubMed ID: 1356339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the multiple drug resistance gene (mdr-1) and epitope masking in chronic lymphatic leukaemia.
    Cumber PM; Jacobs A; Hoy T; Fisher J; Whittaker JA; Tsuruo T; Padua RA
    Br J Haematol; 1990 Oct; 76(2):226-30. PubMed ID: 1709806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-drug resistance in chronic lymphocytic leukemia.
    Friedenberg WR; Spencer SK; Musser C; Hogan TF; Rodvold KA; Rushing DA; Mazza JJ; Tewksbury DA; Marx JJ
    Leuk Lymphoma; 1999 Jun; 34(1-2):171-8. PubMed ID: 10350346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity of adriamycin, idarubicin, and vincristine in acute myeloid leukemia: chemosensitization by verapamil in relation to P-glycoprotein expression.
    Müller MR; Lennartz K; Boogen C; Nowrousian MR; Rajewsky MF; Seeber S
    Ann Hematol; 1992 Nov; 65(5):206-12. PubMed ID: 1360820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
    Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
    Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and northern blot analysis.
    Wulf G; Kluding H; Ho AD; Doerner M; Doehner H; Manegold C; Hunstein W
    Leuk Res; 1994 Jul; 18(7):475-84. PubMed ID: 7912754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of reversing effect of cyclosporin A on vincristine resistance by anti-P-glycoprotein monoclonal antibody MRK-16.
    Naito M; Tsuge H; Kuroko C; Tomida A; Tsuruo T
    Jpn J Cancer Res; 1993 May; 84(5):489-92. PubMed ID: 8100562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between functional and molecular analysis of mdr1 P-glycoprotein in human solid-tumor xenografts.
    Broxterman HJ; Feller N; Kuiper CM; Boven E; Versantvoort CH; Teerlink T; Pinedo HM; Lankelma J
    Int J Cancer; 1995 Jun; 61(6):880-6. PubMed ID: 7790125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy.
    Grogan TM; Spier CM; Salmon SE; Matzner M; Rybski J; Weinstein RS; Scheper RJ; Dalton WS
    Blood; 1993 Jan; 81(2):490-5. PubMed ID: 8093668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U; Walther W; Shoemaker RH
    J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SDZ PSC-833--a novel potent in vitro chemosensitizer in multiple myeloma.
    Jonsson B; Nilsson K; Nygren P; Larsson R
    Anticancer Drugs; 1992 Dec; 3(6):641-6. PubMed ID: 1363199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.